HealthDay: Is new clot-busting medication better treatment for stroke?
UC expert says encouraging early findings need further study
Researchers are studying if a new "clot-busting" drug might be safer than the current treatment for strokes caused by brain bleeds.
The drug, tenecteplase, is currently approved for treating heart attacks but has not received FDA approval as a stroke treatment.
Joseph Broderick, MD, professor in UC’s Department of Neurology and Rehabilitation Medicine in the College of Medicine, director of the UC Gardner Neuroscience Institute and a UC Health physician, told HealthDay the new drug is easier to administer and is less costly than current standard treatments. However, early results showing its effectiveness in patient case studies need to be replicated in formalized clinical trials.
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
Related Stories
UC Cancer Center taps new director
February 11, 2026
The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.
UC researcher adds Chicago collaboration
February 11, 2026
University of Cincinnati research examining how public art and murals influence foot traffic, neighborhood vitality and economic development is now shaping planning conversations well beyond Cincinnati.
UC trial tests new nonpharmacological treatments for depression
February 11, 2026
The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.